Publications - Adrenoleukodystrophy

Back to Areas of Research list.  

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil). Rasmussen, M., Moser, A.B., Borel, J., Khangoora, S. and Moser, H.W. Neurochem. Res. 19:1073-1082, 1994. [paper] 

Contrast-enhanced ex vivo MR reveals inflammaroty zone in X-linked adrenoleukodystrophy. Eichler, F., Garpfalo, K., Moser, A., Selig, M., Hubbard, W. and Blackwell, M. SFN, 2008. [abstract] 

Correlation of very long fatty acids accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Paintlia, A.S., Gilg, A.G., Khan, M., Singh, A.K., Barbosa, E., and Singh, I. Neurobiology of Disease 14: 425-439, 2003. [paper] 

Cytokine-induced accumulation of very long chain fatty acids in C6 glial cells. Khan, M., Pahan, K. and Singh, I. J. Neurochem. 69:S181, 1997. [abstract] 

Cytokine-induced accumulation of very long chain fatty acids in C6 glial cells: implication for X-adrenoleukodystrophy. Khan, M., Pahan, K. and Singh, I. J. Neurochem. 71: 78-87, 1998. [paper] 

Cytokines and inflammation in adrenoleukodystrophy. McGuinness, M.C., Griffin, D.E., Powers, J.M., Moser, H.W. and Smith, K.D. Intern. Soc. for Neurochemistry, Kyoto, Japan, July, 1995. [abstract] 

Cytokines and inflammatory demyelinative lesions in adrenoleukodystrophy and multiple sclerosis. McGuinness, M.C., Wesselingh, S.L., Griffin, D.E., Powers, J.M., Moser, H.W. and Smith, K.D. J. Neuropath. Exp. Neurol. 52:331, 1993. [abstract] 

Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M. and Aubourg, P. Human Molecular Genetics, 14(10): 1293-1303, 2005. [paper] 

Host participants in the early white matter lesion of adrenoleukodystrophy. Ito, M., Moser, A.B., Moser, H.W., Smith, K.D. and Powers, J.M. JNEN 60: 506, 2002. [abstract] 

Human leukocyte antigens and cytokine expression in cerebral inflammatory demylinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. McGuiness, M.C., Powers, J.M., Bias, W.B., Schmeckpeper, B.J., Segal, A.H., Gowda, V.C., Wesselingh, S.L., Berger, J., Griffin, D.E. and Smith, K.D. J. Neuroimmun. 75 (1-2): 174-182, 1997. [paper] 

Inducible nitric oxide synthetase in the central nervous system of patients with X-adrenoleukodystrophy. Gilg, A.G., Singh, A.K. and Singh, I. J. Neuropath. Expt. Neurol. 59:1063-1069, 2000. [paper] 

Is microglial apoptosis an early pathogenic change in cerebral X-Linked adrenoleukodystrophy? Eichler, F., Ren, J., Cossoy, M., Rietsch, A., Nagpal, S., Moser, A., Frosch, M. and Ransohoff, R. Ann Neurol 63: 729-742, 2008. [paper] 

Microglial distribution in X-linked adrenoleukodystrophy: clues to the pathogenesis of cerebral demyelination. McCampbell, A., Eichler, F., Cossoy, M., Herlitz, A. and Ransohoff, R. SFN, 2006 [abstract] 

Potential environmental and host participants in the early white matter lesions of adrenoleukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid Antigen Ppesentation. Ito, M., Blumberg, B., Mock, D., Goodman, A., Moser, A., Moser, H. Smith, K. and Powers, J. JNEN 60: 1004-1019, 2001. [paper] 

Proapoptotic transcription factor p53 is upregulated in the generating wobbler mouse spinal cord. Citron, B., Dennis, J., and Eve, D. SFN, 2006. [abstract] 

Semi-quantitative analysis of cytokines in inflammatory demyelinative lesions in X-linked adrenoleukodystrophy and multiple sclerosis. McGuinness, M.C., Griffin, D.E., Powers, J.M., Moser, H.W. and Smith, K.D. Amer. Soc. of Human Genetics, 1995. [abstract] 

The role of inflammatory mediators in the pathophysiology of X-ALD disease. Paintlia, A.S., Singh, A.K. and Singh, I. ASN, 2002. [abstract]